Traditional Phase 1, 2, and 3 oncology trials are becoming increasingly difficult and time-consuming due to the number of different genetic mutations and cancer types that continue to be discovered.
Basket trials have emerged as an innovative new trial design that can significantly speed the drug development process, but adoption of this new study design can be complicated. High startup costs, complex protocols, contract complications and regulatory approval are some of the biggest obstacles that can prevent trial completion and ultimately delay an effective medicine reaching a patient.
In this webinar, Incyte, a leading biopharmaceutical research company specializing in innovative oncology medicines, discusses the implementation of Bayesian Futility Analysis in basket trials and how they utilized Suvoda’s IRT system to decrease start-up time and mitigate risks while addressing specific business needs. This webinar will go through Incyte’s clinical protocol in case study format and how Suvoda’s IRT system helped simplify the complexities commonly facing oncology trials. The webinar will review the procedures and methods of validation involved in translating data into the IRT system, and how Suvoda helped Incyte successfully implement Bayesian Futility Analysis.
Register for this webinar to discover:
- The benefits of Bayesian Futility Analysis implementation for your study and study teams
- How to ensure accuracy between the results of Suvoda’s IRT system and your statistical program
- The importance of this study approach for future oncology studies